Page last updated: 2024-12-08
2,3-dihydro-1,4-benzothiazine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2,3-dihydro-1,4-benzothiazine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 151064 |
| CHEMBL ID | 1622411 |
| SCHEMBL ID | 88911 |
| MeSH ID | M0256604 |
Synonyms (29)
| Synonym |
|---|
| BB 0218917 |
| 3,4-dihydro-2h-benzo[1,4]thiazine |
| 3,4-dihydro-2h-1,4-benzothiazine |
| STK504009 |
| 3080-99-7 |
| AKOS000117069 |
| HMS1630K02 |
| NCGC00245421-01 |
| 2,3-dihydro-1,4-benzothiazine |
| 2h-1,4-benzothiazine, 3,4-dihydro- |
| EN300-06758 |
| AM803670 |
| FT-0677672 |
| 5B-009 |
| 3,4-dihydro-2h-benzo[b][1,4]thiazine |
| c8h9ns |
| SCHEMBL88911 |
| thiaphenomorpholine |
| benzothiomorpholine |
| 4h-1,4-benzothiazine, 2,3-dihydro- |
| CHEMBL1622411 |
| mfcd04038593 |
| DTXSID20184811 |
| 2,3-dihydro-4h-1,4-benzothiazine |
| CS-0006415 |
| F1935-0005 |
| SY079423 |
| 6-pyrazol-1-yl-nicotinicacidmethylester |
| Z56943460 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (3)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.87
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.87) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||